Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01848483 · ClinicalTrials.gov registry record · NA
Living Well Project for Persons With AIDS
A NA study of Acquired Immunodeficiency Syndrome (AIDS), sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
- 1
- Study location
NCT01848483: Completed NA study of Acquired Immunodeficiency Syndrome (AIDS), sponsored by Emory University.
NCT01848483 is a NA study of Acquired Immunodeficiency Syndrome (AIDS) that has completed, run by Emory University. The registered enrollment target is 121 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01848483, a NA study of Acquired Immunodeficiency Syndrome (AIDS), has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this project is to implement and test the efficacy of an enhanced comprehensive multidisciplinary early palliative care (EPC) package that includes four motivational interviewing sessions (MI) for persons diagnosed with AIDS. We posit that the innovative EPC will improve quality of life, clinical and psychosocial outcomes and advance care planning in a cost effective manner and could promote engagement and retention in HIV care. If successful, it could serve as a model of early palliative care for persons with AIDS in the US.
Primary Outcome
Change in Quality of Life (QOL) as measured by the McGill Quality of Life Questionnaire (MQOL) The MQOL has been widely used with persons with a life-threatening illness, including HIV/AIDS. It contains questions about physical wellbeing, physical symptoms, psychological symptoms, existential wellbeing and support in the past 2 days.A total score was computed.Scores range from 0 to 10 with higher scores indicating better perceived quality of life.
Conditions Studied
Interventions
- OTHER Standard of Care (SOC)
- BEHAVIORAL AIDS EPC Package plus MI
Study Locations (1)
Georgia
- Emory University, Nell Hodgson Woodruff School of Nursing - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2014-06 |
| Est. Completion | 2017-06 |
| Phase | NA |
What the finished NCT01848483 record still lists
NCT01848483 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Acquired Immunodeficiency Syndrome (AIDS) appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care (SOC) is the first listed.
NCT01848483 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT01848483 about?
NCT01848483 is a clinical study titled "Living Well Project for Persons With AIDS". The overall goal of this project is to implement and test the efficacy of an enhanced comprehensive multidisciplinary early palliative care (EPC) package that includes four motivational interviewing sessions (MI) for persons diagnosed with AIDS. We posit that the innovative EPC will improve quality ...
What is the current status of trial NCT01848483?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2014-06. Estimated completion is 2017-06.
What conditions does trial NCT01848483 study?
This clinical trial studies the following conditions: Acquired Immunodeficiency Syndrome (AIDS).
What interventions are being tested in trial NCT01848483?
The interventions under investigation include: Standard of Care (SOC) (OTHER), AIDS EPC Package plus MI (BEHAVIORAL).
Who is sponsoring clinical trial NCT01848483?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01848483 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acquired Immunodeficiency Syndrome (AIDS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01848483's enrollment target sits among peer trials
121 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia